Related Experiment Video
Updated: Feb 1, 2026

Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of
Maria R Farcet1, Jens Modrof1, Philip O Rabel1
1Global Pathogen Safety, Vienna, Austria.
Background:
Wild-type poliovirus may be eradicated soon and under WHO GAPIII guidance, laboratory use will be discontinued or subject to strict containment. Per US Code of Federal Regulations, however, immunoglobulin lot release testing will still require use of replicating poliovirus. The suitability of S19 hyper-attenuated and apathogenic poliovirus strains as alternatives to the currently used wild-type virus in such a release assay was investigated.
Study Design And Methods:
S19 poliovirus strains were propagated in a commercial setting using good virological practices and maintenance of the S19 hyper-attenuated genotype was confirmed by massively parallel sequencing.
Results:
The attenuated phenotype of the produced S19 stocks was confirmed in a highly sensitive mouse-model. Equivalency in performance was seen in the lot release assay for the S19 and wild-type polioviruses.
Conclusion:
The deployment of such hyper-attenuated and thoroughly characterized S19 stocks in these and other essential activities might reconcile final containment measures with continued safe use of poliovirus.
Insights
Hyper-attenuated poliovirus strains (S19) can replace wild-type poliovirus for immunoglobulin lot release testing. This ensures continued safe use of poliovirus while supporting global eradication efforts.
Area of Science:
- Virology
- Immunology
Background:
- Wild-type poliovirus eradication is imminent, necessitating strict containment or discontinuation of laboratory use.
- US regulations require replicating poliovirus for immunoglobulin lot release testing.
- Investigating S19 poliovirus strains as alternatives to wild-type virus is crucial.
Purpose of the Study:
- To assess the suitability of S19 hyper-attenuated poliovirus strains for immunoglobulin lot release assays.
- To determine if S19 strains can serve as safe and effective replacements for wild-type poliovirus.
Main Methods:
- S19 poliovirus strains were propagated under good virological practices.
- Massively parallel sequencing confirmed the S19 hyper-attenuated genotype.
- The attenuated phenotype was validated in a sensitive mouse model.
Main Results:
- Propagation and characterization of S19 poliovirus stocks were successful.
- S19 strains demonstrated an attenuated phenotype in vivo.
- S19 and wild-type polioviruses showed equivalent performance in lot release assays.
Conclusions:
- Hyper-attenuated S19 poliovirus stocks are suitable alternatives for immunoglobulin lot release testing.
- These characterized S19 stocks reconcile containment measures with essential poliovirus use.
- Deployment of S19 strains supports both poliovirus eradication and ongoing laboratory needs.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
In Vitro Drug Release Testing: Overview, Development and Validation
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Null and Alternative Hypotheses
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...

